THANKS TO LEGAL CANNABIS, HEMP PRODUCTS ARROW

Hemp has been used in various applications for thousands of years. Its cultivation in Italy began to develop more from the 18th century, a moment in which cultivations intensified also thanks to the massive use in textiles .

According to the results of the research, according to the WHO, it does not appear that cannabis can have negative effects comparable to the other substances present in the IVth table and has instead underlined its therapeutic potential for treating and alleviating symptoms of various pathologies, especially chronic pain and other diseases such as epilepsy and multiple sclerosis. Additionally, he points out that THC has similar effects to cannabis and cannabis resin, which is why it makes sense for these substances to have the same classification.THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol) are two cannabinoids found in cannabis sativa, and both have effects on receptors in the human body and brain. THC is the main psychoactive component of cannabis, responsible for the sensation of “high” obtained. Its effects may include relaxation, altered senses, appetite, fatigue and reduced aggression. THC can also help counteract the negative effects of chemotherapy and multiple sclerosis cbd vegan gummy

CBD is not psychoactive even though it has the same chemical formula as THC. It is therefore possible to use it for therapeutic purposes without experiencing significant effects on cognitive abilities. It can help with chronic pain and depression Vegan CBD Gummies.

The WHO declares that there are no known negative effects of cannabidiol (CBD), which can instead be used for medical purposes; for example, its use has already been recognized in the United States as a treatment for childhood epilepsy.

It is important to remember that despite being prohibited by international conventions, a growing number of state-level legislation in the USA and in countries such as Uruguay, Canada, Mexico and Jamaica are legalizing cannabis for non-medical-scientific uses, while the number of which allow its therapeutic use like Italy.

The proposed reclassification of cannabis was awaited news by all those who have been fighting for years to regulate the production, consumption and trade of the Indica cannabis plant and its derivatives. The proposal was not put to the vote during the last session of the Commission on Narcotic Drugs on March 18, as the communication of the recommendation came only two months earlier and therefore outside the time limit of at least three months set by the regulation on classification of substances. Despite this, the WHO’s position on cannabis speaks clearly and places the responsibility of the States to respond with adequate standards.